The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kikuchi-Maki, A.
Right arrow Articles by Campbell, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kikuchi-Maki, A.
Right arrow Articles by Campbell, K. S.
The Journal of Immunology, 2005, 174: 3859-3863.
Copyright © 2005 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: KIR2DL4 Transduces Signals into Human NK Cells through Association with the Fc Receptor {gamma} Protein1

Akiko Kikuchi-Maki, Tracey L. Catina and Kerry S. Campbell2

Fox Chase Cancer Center, Institute for Cancer Research, Philadelphia, PA 19111

KIR2DL4 (2DL4, CD158d), a member of the human killer cell Ig-like receptor (KIR) family, triggers potent IFN-{gamma} responses but weak cytotoxicity in resting NK cells. 2DL4 mRNA has been detected in most NK cell clones from most humans examined, but surface protein expression is detectable only on CD56high NK cells from certain donors. The receptor possesses a transmembrane arginine residue, suggesting association with a signaling accessory protein that has remained elusive. We provide biochemical and functional evidence that Fc{epsilon}RI-{gamma} ({gamma}) associates with 2DL4 to promote surface expression and provide signal transducing function. Weak cytolytic responses triggered through 2DL4 may result from low stoichiometric association with {gamma}. Selective association with {gamma} distinguishes 2DL4 from all other activating forms of the KIR family, which alternatively associate with DNAX-activating protein (DAP)12.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. M. Shahjahan Miah, T. L. Hughes, and K. S. Campbell
KIR2DL4 Differentially Signals Downstream Functions in Human NK Cells through Distinct Structural Modules
J. Immunol., March 1, 2008; 180(5): 2922 - 2932.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. H. Chewning, C. N. Gudme, K. C. Hsu, A. Selvakumar, and B. Dupont
KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro
J. Immunol., July 15, 2007; 179(2): 854 - 868.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Estefania, R. Flores, N. Gomez-Lozano, H. Aguilar, M. Lopez-Botet, and C. Vilches
Human KIR2DL5 Is an Inhibitory Receptor Expressed on the Surface of NK and T Lymphocyte Subsets
J. Immunol., April 1, 2007; 178(7): 4402 - 4410.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Alvarez-Errico, J. Sayos, and M. Lopez-Botet
The IREM-1 (CD300f) Inhibitory Receptor Associates with the p85{alpha} Subunit of Phosphoinositide 3-Kinase
J. Immunol., January 15, 2007; 178(2): 808 - 816.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Wendt, E. Wilk, S. Buyny, J. Buer, R. E. Schmidt, and R. Jacobs
Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells
J. Leukoc. Biol., December 1, 2006; 80(6): 1529 - 1541.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. T. Bryceson, M. E. March, H.-G. Ljunggren, and E. O. Long
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
Blood, January 1, 2006; 107(1): 159 - 166.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
A. P. Williams, A. R. Bateman, and S. I. Khakoo
HANGING IN THE BALANCE: KIR and Their Role in Disease
Mol. Interv., August 1, 2005; 5(4): 226 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
L. Abi-Rached and P. Parham
Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues
J. Exp. Med., April 18, 2005; 201(8): 1319 - 1332.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.